Xilio Therapeutics, Inc. (XLO)
8.42
-0.17
(-1.98%)
USD |
NASDAQ |
Apr 15, 16:00
8.42
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics Research and Development Expense (Annual) : 56.04M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 14.83B |
| Merck & Co., Inc. | 12.51B |
| Pfizer Inc. | 10.25B |
| Verastem, Inc. | 114.60M |
| Sensei Biotherapeutics, Inc. | 10.96M |